Firstsource Solutions Ltd

- No explicit mention of current or future fundraising through debt or equity in the provided transcript. - The company discusses improving margins, acquisitions (like PDC pending regulatory approval), and operational efficiencies but does not indicate plans for new debt or equity raises. - Net debt reduced from Rs 13.2 billion (March 2025) to Rs 11.2 billion (June 2025), suggesting no immediate need for additional debt. - Focus appears to be on organic growth, margin expansion, and selective acquisitions that are EBIT and EPS accretive. - No stated plans for equity fundraising or new debt issuance in the discussed quarters or near-term outlook.

- Firstsource is actively investing in expanding its execution infrastructure, adding new seating capacities in Mumbai, Bangalore, and Gurugram in Q1 FY26. - They are continuing to invest in technology, AI, and automation across the lifecycle of engagements to drive efficiencies. - Significant investments are being made in automating volume hiring processes using AI, aiming to automate two-thirds of volume hiring by March 2026, reducing hiring cycle time by up to 50%. - The company has signed a share purchase agreement to acquire Pastdue Credit Solutions (PDC) in the UK, a strategic acquisition subject to FCA approval, expected to close in the current quarter; this will be margin and EPS accretive. - Capital expenditure normalization has improved free cash flow to PAT to 196% in Q1 FY26. - Continued strategic focus on acquisitions that add capabilities or market access, rather than for revenue alone.

- Q1 FY26 revenue was Rs 22.2 billion (~US$259 million), showing a 23.8% YoY growth and 3.6% QoQ growth in USD terms. - Revenue growth driven by 17 new client logos, including 9 strategic logos with potential for $5mn+ relationships. - Strong deal pipeline, the highest in company history, especially large, multi-year, transformative programs with non-linear ramp-ups. - Banking & Financial Services vertical showed flat QoQ growth but 7% YoY growth in constant currency; healthcare and CMT verticals showed solid expansion. - Geographic growth: North America grew 5% QoQ and 22% YoY; Europe down 7% QoQ but expected to normalize. - Continued opportunity from onshore to offshore shift and AI-driven efficiency improvements expected to support margin and revenue growth. - The company expects an accelerated growth trajectory in FY26 based on deal pipeline and strategic initiatives like the UnBPO playbook and AI investments.

- Firstsource Solutions expects continued industry-leading growth in FY26 despite macroeconomic uncertainties, backed by a robust pipeline and strong deal wins. - EBIT margin guidance for FY26 is maintained in the band of 11.25% to 12%, with an anticipated annual margin improvement of 50 to 75 basis points starting FY26. - Profit after tax grew by 25.2% YoY in Q1FY26, and margins expanded sequentially by 10 bps, indicating steady profitability gains. - The company aims to build a consistent, predictable, and high-growth business model, focusing on longer-term strategic aspirations. - Investments in AI, automation, and right-shoring strategies are expected to drive margin improvement and operational efficiencies. - Acquisition strategy favors EBIT and EPS accretive deals to enhance capabilities and accelerate growth without focusing solely on revenue. - Strong cash conversion and improved working capital management support financial health and future earnings growth prospects.

- Firstsource exited Q1 FY26 with the highest qualified deal pipeline in the company’s history. - Added 17 new logos in Q1, including 9 strategic logos, broadening the client base. - Large deal wins have been consistent for five quarters, with multi-year, sole-source deals featuring non-linear commercial constructs. - Recent large deal wins support confidence in sustaining industry-leading growth in FY26 despite macro uncertainties. - The pipeline includes transformational programs and disruptive deals such as a $50 million+ ACV BPaaS deal with a mid-market U.S. health plan. - Growth in key verticals like Healthcare, CMT, and North America remains healthy, with ongoing ramp-ups in recently won deals. - Overall, strong visibility from the robust deal pipeline underpins an expected accelerating growth trajectory.